These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 36611025

  • 21. Dynamic changes and multiplication rate of white blood cell count may direct the timing of cytoreduction chemotherapy during induction treatment in newly diagnosed acute promyelocytic leukemia with low-intermediate risk.
    Wen J, Xu F, Zhou Q, Hu H, Liu Y, Su J, Zhang Y, Qu W, Shi L.
    Mol Clin Oncol; 2021 Jun; 14(6):112. PubMed ID: 33903818
    [Abstract] [Full Text] [Related]

  • 22. Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials.
    Micol JB, Raffoux E, Boissel N, Lengliné E, Canet E, Daniel MT, Labarthe Ad, Maarek O, Cassinat B, Adès L, Baruchel A, Degos L, Azoulay E, Dombret H.
    Eur J Cancer; 2014 Apr; 50(6):1159-68. PubMed ID: 24440088
    [Abstract] [Full Text] [Related]

  • 23. [Clinical features and prognostic analysis of high-risk acute promyelocytic leukemia patients].
    Pei RZ, Si T, Lu Y, Zhang PS, Liu XH, Ye PP, Chen D, Du XH, Ma JX, Jin J.
    Zhonghua Xue Ye Xue Za Zhi; 2016 May 14; 37(5):360-5. PubMed ID: 27210868
    [Abstract] [Full Text] [Related]

  • 24. Analysis of risk factors for early death in patients with acute promyelocytic leukaemia treated with arsenic trioxide.
    Wang Y, Hou W, Li H, Tian X, Li J, Hu T, Shi D, Zhang Y.
    Ann Hematol; 2022 May 14; 101(5):1039-1047. PubMed ID: 35174404
    [Abstract] [Full Text] [Related]

  • 25. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 May 14; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 26. Comparative analysis of causes and predictors of early death in elderly and young patients with acute promyelocytic leukemia treated with arsenic trioxide.
    Jin B, Zhang Y, Hou W, Cao F, Lu M, Yang H, Tian X, Wang Y, Hou J, Fu J, Li H, Zhou J.
    J Cancer Res Clin Oncol; 2020 Feb 14; 146(2):485-492. PubMed ID: 31686248
    [Abstract] [Full Text] [Related]

  • 27. Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts.
    Ono T, Takeshita A, Kishimoto Y, Kiyoi H, Okada M, Yamauchi T, Emi N, Horikawa K, Matsuda M, Shinagawa K, Monma F, Ohtake S, Nakaseko C, Takahashi M, Kimura Y, Iwanaga M, Asou N, Naoe T, Japan Adult Leukemia Study Group.
    Cancer Sci; 2014 Jan 14; 105(1):97-104. PubMed ID: 24206578
    [Abstract] [Full Text] [Related]

  • 28. Clinical outcomes of therapeutic leukapheresis in acute promyelocytic leukemia: A single-center retrospective cohort study.
    Lee H, Yoon JH, Cho BS, Kim HJ, Jekarl DW, Kim Y.
    Cytotherapy; 2023 Jun 14; 25(6):659-669. PubMed ID: 36774295
    [Abstract] [Full Text] [Related]

  • 29. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H, Zhu CY, Wang QS, Niu JH, Zhang Q, Zhu HY, Yao ZL, Xu YY, Jing Y, Yu L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr 14; 22(2):315-22. PubMed ID: 24762998
    [Abstract] [Full Text] [Related]

  • 30. Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia.
    Xiao M, Zhou P, Liu Y, Wei S, Li D, Li W, Niu X, Niu J, Zhang Y, Cao W, Liu B, Wang X, Bai Y, Sun K.
    Thromb Res; 2022 Feb 14; 210():33-41. PubMed ID: 34998209
    [Abstract] [Full Text] [Related]

  • 31. Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial.
    de Botton S, Chevret S, Coiteux V, Dombret H, Sanz M, San Miguel J, Caillot D, Vekhoff A, Gardembas M, Stamatoulas A, Conde E, Guerci A, Gardin C, Fey M, Cony Makhoul D, Reman O, de la Serna J, Lefrere F, Chomienne C, Degos L, Fenaux P, European APL group.
    Leukemia; 2003 Feb 14; 17(2):339-42. PubMed ID: 12592333
    [Abstract] [Full Text] [Related]

  • 32. [Relationship between Peripheral Blood White Blood Cell Count and Early Death Rate in Patients with Acute Promyelocytic Leukemia].
    Wang HY, Zhang XX, Zhang HY, Wang J, Chen LM, Wang MC, Xi JY, Xie M, Fan T.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun 14; 25(3):718-722. PubMed ID: 28641624
    [Abstract] [Full Text] [Related]

  • 33. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
    Testa U, Lo-Coco F.
    Ann Hematol; 2016 Apr 14; 95(5):673-80. PubMed ID: 26920716
    [Abstract] [Full Text] [Related]

  • 34. Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.
    Kelaidi C, Chevret S, De Botton S, Raffoux E, Guerci A, Thomas X, Pigneux A, Lamy T, Rigal-Huguet F, Meyer-Monard S, Chevallier P, Maloisel F, Deconinck E, Ferrant A, Fegueux N, Ifrah N, Sanz M, Dombret H, Fenaux P, Adès L.
    J Clin Oncol; 2009 Jun 01; 27(16):2668-76. PubMed ID: 19414681
    [Abstract] [Full Text] [Related]

  • 35. CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy.
    Ferrara F, Morabito F, Martino B, Specchia G, Liso V, Nobile F, Boccuni P, Di Noto R, Pane F, Annunziata M, Schiavone EM, De Simone M, Guglielmi C, Del Vecchio L, Lo Coco F.
    J Clin Oncol; 2000 Mar 01; 18(6):1295-300. PubMed ID: 10715300
    [Abstract] [Full Text] [Related]

  • 36. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group.
    Asou N, Adachi K, Tamura J, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Akiyama H, Tsubaki K, Saito K, Kuriyama K, Oh H, Kitano K, Miyawaki S, Takeyama K, Yamada O, Nishikawa K, Takahashi M, Matsuda S, Ohtake S, Suzushima H, Emi N, Ohno R.
    J Clin Oncol; 1998 Jan 01; 16(1):78-85. PubMed ID: 9440726
    [Abstract] [Full Text] [Related]

  • 37. Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial.
    Burnett AK, Grimwade D, Solomon E, Wheatley K, Goldstone AH.
    Blood; 1999 Jun 15; 93(12):4131-43. PubMed ID: 10361110
    [Abstract] [Full Text] [Related]

  • 38. Reduction of pulmonary toxicity by prednisolone prophylaxis during all-trans retinoic acid treatment of acute promyelocytic leukemia. Australian Leukaemia Study Group.
    Wiley JS, Firkin FC.
    Leukemia; 1995 May 15; 9(5):774-8. PubMed ID: 7769839
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.